Overview
- BillionToOne priced 4,551,100 shares of Class A common stock at $60 per share in its upsized offering.
- The company expects its shares to begin trading on the Nasdaq Global Select Market on November 6 under the ticker BLLN.
- Underwriters received a 30-day option to buy up to 682,665 additional shares at the IPO price, less discounts and commissions.
- The offering is expected to close on November 7, subject to customary closing conditions.
- Headquartered in Menlo Park, BillionToOne develops molecular diagnostics using its patented Quantitative Counting Templates platform for single‑molecule DNA counting.